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ABSTRACT
PRESCRIPTION DESIGN FOR THE IMPAIRED
Amber Kleitz
May 2018
This thesis is a critical analysis of the state
of prescription drug packaging in the United States
with respect to unresolved problems for users with
visual, physical, and cognitive impairments. It begins
with an anecdotal overview inspired by Deborah Adler’s
journey of prescription drug packaging for her
grandparents and her design solution outlined by a
case study. This case study focuses on the need for
better prescription packaging for those with the
aforementioned and neglected issues.
This thesis uses studies in user-centered design,
packaging design, and industrial design among others
in order to critically assess and question the current
state of user experience for those with impairments.
The latter part of the thesis argues that a
universal standard would be difficult to implement due
to logistical challenges of the private sector of
pharmaceutical companies.
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INTRODUCTION
One of the most essential parts of growing old is
maintaining a healthy body. As natural decline creeps in on
daily life, routine visits to a physician and careful
attention to prescribed drugs become increasingly important
and sometimes the central focus in life. The misuse of
taking the necessary prescription medication to live a
healthy life is a problem adults over the age of 65 in the
United States face. Sadly, this is due to problems of a
long history of poorly and inconsistently designed
prescription packaging. For those who prefer to live
independently from any home-care, assisted living, or
family members, things that used to be simple suddenly
become risks.
This thesis will address the main factors that affect
the efficiency of a prescription design including, but not
limited to, visual, physical, and cognitive impairment. All
three of these factors currently affect adults in the
United States. Adults over the age of 65 count for 30% of
the United States pharmaceutical expenditures, although
they only account for 13% of the total population. By
researching the problems this population faces. Products
that have hit the market in attempt to resolve these
problems and I hope to propose a robust solution that may
"1

be tested by pharmaceutical companies. A viable solution
could lead to a national standard policy.
I am not the first to assume this is possible. In
fact, another designer was faced with the same familial
experience for her work with Target Pharmacy, Clear Rx.
This case study was inspired by her grandparents taking
each others’ medicine by mistake. With the same first
initial and last name and a similar looking bottle, the
label was rendered useless if given little attention. This
designer, Deborah Adler, created a system for her
grandparents to quickly identify whose medicine they were
looking for by simple use of a colored band around the top.
In addition, she was able to address further concerns of
the hierarchy of most necessary information and custom made
iconography that lessened the need for phrases that would
otherwise take up valuable space on such a small surface.
Despite the great design success that Clear Rx was,
Adler wasn’t finished. Adler Design partnered with CVS
Pharmacy to recreate a new system for labeling the classic
amber-colored pill bottles. This new labeling system
features daily routine instructions by using a simple table
utilizing color and iconography. Because this label did not
need to change the physical design of the bottle, it was
much easier for the large pharmaceutical company to adopt
than if they had to change the physical production of the
bottle itself.
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Of these two case studies that will be explored later
on, they address different inhibitors separately and
without relation to another. Clearly there is no one-fix
solution for all – at least not at this point in time. The
goal is to evaluate what we know about the most common
inhibitors of accurate prescription handling and theorize
what we are currently able to test. If there is a solution
or a system of small solutions that would be easy to adopt,
the user experience of a daily routine could be seamless
with as little mental pain points as possible.
There will be three outlined directions to address
the issues I stated. The first concern is that of the most
common visual impairments including refractive errors,
cataract, glaucoma, diabetic retinopathy, and macular
degeneration. The second concern will address physical
impairments such as arthritis, limited dexterity of hands,
carpal tunnel, cerebral palsy, and multiple sclerosis. The
last impairment to be addressed is that of a cognitive
nature. This impairment is too vast to address all aspects
in focus, so I will only address the conditions in the
stages before the patient is no longer able to
independently perform daily activities. These conditions
include types of amnesic and non-amnesic Memory Cognitive
Impairment, Wernicke-Korsakoff Syndrome, and types of
dementia including Alzheimers.
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VISUAL IMPAIRMENT
The most commonly addressed problem in pharmaceutical
packaging and the design community is visual impairment.
Age-related vision loss is very common, and is responsible
for a large amount of responsibility as a cause of medicine
mis-adherence. Most common types of impairment include
refractive errors such as near-sightedness, farsightedness, and the like. These cases account for 42% of
the total number of reported visual impairment cases.
Following refractive errors, impairments such as cataracts,
glaucoma, age-related macular degeneration (AMD), and
diabetic retinopathy also cause a serious risk for misadherence.
Symptoms of blurry or patchy vision and clouding of
the lens make it very difficult for a patient to read any
words on a label. This label contains vital information
that a patient needs to know to decrease risk or harm to
themselves. The name of the patient, the prescription name,
and the instructions are the most important parts of the
label and if misread, the prescription is useless. There
are solutions that are already being implemented or tested
to address a number of these issues.
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COLOR
The first and most obvious solution would be the use
of color. In a study with a population of 126 glaucoma
patients, 65% claimed to use color as a way of organizing
their medication (Brandt, 2015).
There are traditionally three main elements of a pill
bottle that color can intentionally be used to mark special
attributes to the medication - the cap, label, and bottle
walls. Warning stickers also serve a purpose with colors
that are meant to grab attention, like orange cautionary
labels. Unfortunately, the color of the label blends in
with the current standard amber bottles and a sticker added
post-printing may obstruct important information for the
patient.
A solution called Clear RX implemented colored rings
helped to identify ownership in a multi-person household.
The patient chooses one of six colors to be included on the
neck of a bottle as a ring or as a sticker on a
prescription that does not utilize a bottle design. This
project was conceived by Deborah Adler for her masters
thesis in collaboration with an industrial designer, Andrew
Koch. There was significant research and user testing that
went into this project as the patents are iterative and
reveal much of the reasoning behind the design. However,
there are a number of problems with resorting to only
changing the color of the cap or ring of a medication.
There are multiple approaches in the use of color on a
"5

prescription bottle including time of day to take it, who
the medication is for, and the type of medication.
Different methods of color usage on a package make the
system unreliable and creates inherent risk for patients.
Many older adults take more than one type of
medication and the possibility of switching a cap is
alarmingly common. Doctors can not trust that patients will
always remember to only open one prescription at a time or
to check labels in addition to the color, let alone know
the correct spelling of the medication. In a study
involving 102 participants of both doctors and patients,
overall agreement on a color name was very poor. Four
particular medications on a blue-green spectrum had less
the 15% agreement rate. (Pujan, 2015)
Color blindness is a condition most common in males
and has been linked to heredity. There are different
spectrums of color blindness such as red-green and blueyellow (National Eye Institute, 2015).
Glaucoma is a condition that increases in severity as
time goes on, dulling and distorting colors. Eventually a
color system will be rendered uses to these kinds of
patients. Seeing as how there is no cure for glaucoma,
these patients will start to rely on the next solution,
pattern and texture.
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FIGURE 1. CLEAR RX PACKAGING CONCEPT DESIGNED AND
DEVELOPED BY DEBORAH ADLER IN PARTNERSHIP WITH
ANDREW KOCH AND TARGET PHARMACY
IMAGE FROM ADLER DESIGN
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PATTERN & TEXTURE
A second solution involves the use of pattern and
possibly texture. In addition to color, the use of pattern
can supplement quick recognition of specific medications.
For those that are unable to accurately read words without
assistance especially in the cases of close-proximity, the
use of a simple pattern would differentiate even for colorblind patients. The use of only triangles, squares, and
circles might not be enough for patients that have more
than three medications or three others in the household.
However, the composition or repetition in a space would
provide more combinations. For example, on two
prescriptions that use circles in the pattern, one may have
5 circles in a single unit of the repeating pattern, but
the other may have 10, making the second composition much
different in how compact the circles are and their size,
instantly differentiating them. Similarly, squares can be
rotated at 45 degrees to create a diamond shape. In
combination to texture, what would originally be a
perceptual sensation becomes physical as well.
Textured patterns would be most helpful on cap design
so as not to disrupt the important information on the
label. It would also be more difficult to mass-manufacture
a repeating pattern on a cylindrical surface as where a cap
can be flat facing up in a 3D printing process. An example
of this was conceptualized by two students, Ashley Ma and
Alex Broerman at the University of Cincinnati in 2012.
"8

FIGURE 2. “INCLUSIVE PILL BOTTLES FOR THE BLIND”
PACKAGING DESIGN SYSTEM CONCEPT BY ALEX BROERMAN
AND ASHLEY MA AT THE UNIVERSITY OF CINCINNATI, 2012
IMAGE FROM MA’S PORTFOLIO SITE
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Though this design has not been implemented by any major
pharmacies or private merchants, the concept won the
“Innov8 For Health,” competition sponsored by a variety of
companies and institutions. They implemented eight unique
textures for the top on a flip cap lid. It was important to
note that not all visually impaired people read Braille, so
they intended not to use this in the design system. Figure
2 shows the CAD model of their concept, showing six of the
eight designs, including a view of the cap opening. The
colors are vibrant while also being different enough in
brightness and contrast from the other. The pattern is
large enough for tactile recognition for a patients figures
to easily differentiate.
TYPOGRAPHY
Typography could serve as a third solution with
changes to typeface, size, and hierarchy. The typeface
design and size of the wording would be considered a visual
enhancement while the treatment and hierarchy should be
considered a textual enhancement. The two are different in
that one pertains more to how the eye processes shape and
the other relays and interprets messages.
An example of visual enhancement is Maxular Rx, a
typeface currently under development designed by Steve
Skaggs at the University of Louisville. Maxular Rx is the
first font ever to be produced specifically for people with
macular degeneration. Macular degeneration affects central
"10

vision, making crossing roads and reading difficult.
Maxular employs the use of a bold stroke that is uniform in
thickness in order to draw the eye to decipher parts of a
letter which make it most recognizable. Additionally,
avoiding sharp angles in the letterforms helps to avoid
aggravated distortions associated with AMD. This typeface
just finished clinical trials being tested against Times,
Helvetica, Courier, and a new competing AMD typeface called
Eido. So far, Maxular has performed well in the Reading
Acuity (RA) test, the most valuable test point for a
typeface to be used on a prescription label. Reading Acuity
is the measurement of legibility at the smallest print size
to be read. Critical Print Size (CPS) is the smallest print
size for the best reading speed. Maximum Reading Speed is
the measurement of time to speed read the text without the
constraint of print size. These three categories of
measurement are combined to create a MNRead test. This test
showed that Maxular performed better than all other fonts
in RA; in critical reading speed it was second to Courier.
(Xiong, 2017). There was no significant benefit in the
Maximum Reading Speed test. Maxular performed better than
other typefaces due to the attention to the particular
spacing between specific characters in a word, otherwise
known as tracking. It also performed well due to generous
x-height and ample line spacing.
Ligatures, or visually combined letters to create a
single glyph, which is a single character, symbol, or
"11

graphic used in word. Ligatures are carefully formulated
for optimization between legibility and space. For example,
the ligatures fi, ff, fl, and so on may connect at certain
points that do not hinder the individual perception of a
single letter. Figures 1 and 2 show examples of how some
typefaces make a single glyph out of these letter
combinations to the benefit or detriment of its legibility.
Filson Soft and Myriad Pro are two san serif fonts that
employ this strategy in different ways.
Word spacing breaks apart words and create negative
space for the eye to rest and recognize the start of a new
word. Maxular uses 150 units between words which helps as
an extended typeface, helping to clearly separate words.
This reduced crowding between words benefited Maxular in RA
and CPS tests.
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FIGURE 3. FILSON SOFT F-LIGATURES
WITH OPTIMAL KERNING AND 0 TRACKING.

FIGURE 4. MYRIAD PRO F-LIGATURES
WITH OPTIMAL KERNING AND 0 TRACKING.
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An example of a textual enhancement using type would
be Tall Man Lettering. A study at the University of
Aberdeen sought to improve the relationship between
proximity errors, time pressure, and a visual search of
medication names (Irwin, 2012). The first thing to
understand about the importance of readable and clear
medication names is the history of why they look similar.
Drug names that are visually similar have a characteristic
called orthographic similarity. These visually similar
words have nothing to do with the chemical make-up of the
drugs, but rather the brand that created them.
Understandably, this creates an adverse affect on
recognition and memory.
Tall Man lettering was tested in this study to combat
this effect, thus diminishing accidental medication misadherence. Visually similar non-targets (medications NOT to
be taken) and targets (prescribed medication) were placed
together in a controlled space to simulate theories of
visual search. Stimulus properties include the
capitalization of a particular letter, initial, or
combination of letters that differentiate the target from
other non-targets, drawing attention to the relevant
information on the label.
The claim was found to be false after a study with
participants that were not pharmacists. Data collected
indicated that Tall Man lettering was an insufficient form
of textual enhancement for medication labeling,
"14

particularly under time pressure. Reaction time and error
rate were relatively unaffected (Irwin, 2012). Though the
pharmacist population in this experiment indicated this
claim as true, it could be that the frequency of medication
dispensed by the pharmacists contributed to their success
rate. It is understood that further studies may be
necessary to prove the performance of Tall Man lettering.
Further studies could include the use of phonetic emphasis
on words instead. Focusing on how a word sounds may prove
more user-oriented than how it looks, however pronunciation
of a word can differ from user to user especially if the
word has never been used or heard before.
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PHYSICAL IMPAIRMENT
Over 100 different types of arthritis affect
approximately 30 million people in the United States
according to the Georgia Tech Research Institute (2007).
Other common physical disabilities that affect the ease of
opening a prescription bottle include carpal tunnel,
osteoporosis, and more generally hand dexterity limitations
for 15.2 million Americans.
The prevalence of these physical impairments indicates
that there is a strong need for inclusion when
manufacturing the standard bottle and cap design for their
prescription. The bottles that are meant to hold the
medications to soothe their symptoms are the same devices
that are inhibiting the patient from taking them.
The difficulty in opening the lids came from a need in
the 70s and 80s for child resistant design and antitampering. Though this is important, only recently have
there been proposed solutions in cap designs for those with
limited dexterity of the hands. The Arthritis Foundation is
a nationally recognized entity that supports and educates
Americans that are affected by all different types of
arthritis and evaluates companies in relation to how they
stand up to their standards. The Ease of Use Commendation
comes from a test endorsed by the Arthritis Foundation and
"16

conducted by the Intuitive Design Applied Research
Institute (IDARI) who helps companies develop products for
people with limitations like arthritis (arthritis.org). The
first step of getting the Ease of Use Commendation is for a
manufacturer to send their product design to the Arthritis
Foundation for evaluation. From there, the product will go
through a series of “pass/fail” tests conducted by
scientists at IDARI. User tasks such as when the bottle is
removed from its packaging, how it is opened, and how the
pills are removed from the bottle are assessed and
evaluated though multiple uses. After that, a group of
eight research participants are chosen with the criterion
of grip, torque, and muscle strength for moderate to severe
arthritis. Muscle strength is further evaluated for
endurance, pinch force and range of motion. So long as
seven of the eight participants can successfully open the
bottle without pain, the design is approved and rewarded
the Ease of Use Commendation.
The Aleve® Easy Open Soft Grip Arthritis Cap received
the Ease of Use Commendation by the Arthritis Foundation.
The cap is made of an easy-to-grip rubber-like material to
provide traction for those that have arthritis. Though this
medicine is not a prescription given by a pharmacist, the
design could be implemented by manufacturers, such as
Centor, that are used for that purpose.
The 1-Clic Packaging System by Centor also received an
Ease of Use Commendation. The name 1-Clic comes from the a
"17

audible “click” to indicate the closure has been secured
correctly – a feature that encourages consistent and proper
use. The closure is versatile with both child-resistant or
non-child-resistant caps in the case that seniors and
arthritic patients may have children around their medicine.
Although both of these products received the Ease of
Use Commendation, they both require the patient to twist
the cap or utilize their finger strength in some way. This
is a pain point for most arthritis patients. Flip caps and
push-to-open lids enable the patient to use other parts of
their hand to open the bottle while still remaining child
resistant. An example of this is shown in a conceptual
design by Christine Chau. Her solution features a larger
lid that can be opened in at least three ways: the sidepalm of the hand pushing sideways, the bottom-palm of the
hand pushing up vertically, and gripping the lid and
pulling up. This helps arthritic patients with limited
dexterity in their fingers and more strength in the wrist.
In addition, the bottle opening allows enough room for the
patient to reach two fingers into the bottle rather than
pouring the pills out onto the palm. Pouring the pills can
result in the patients accidentally dropping them onto the
ground or into a sink and down the drain, thus creating an
inconvenience and strong pain point. Another example of a
flip cap and push-to-open concept is the previously
mentioned work of Broerman and Ma. Their design implemented
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a simple button that can be pushed by thumb, finger, or
palm in addition to the beneficial visual elements.
Opening a bottle or compartment is just one stage of
opening a prescription. For some, the opening of a bottle
may be too narrow for thick fingers. Others, the size of
the pill requires more dexterity or sensitively in the
finger tips to grasp the bill within the hollow cylinder
and pull or drag the pill out. Patients resort to pouring
the medication into their hands or onto the counter, making
the margin for error much greater with possibilities of
spills.
There is potential now for automatic dispensers that
implement voice control, proximity sensors, and biometric
security. Speculatively speaking, sometime in the near
future, there is a possibility that finger print sensors
will be as common as they are a feature on our phones.
Simple biometric algorithms could act not only as an
unlocking feature to open a lid, but can also work as an
identification feature for multi-person households and
child-resistant packaging. Automatic dispensers are also
closely related to multi-compartment medication devices,
which are helpful for patients that also have early to
middle stages of cognitive impairments. These devices will
be explored in the next section that addresses cognitive
impairments.
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FIGURE 5. ALEVE® EASY OPEN
SOFT GRIP ARTHRITIS CAP
IMAGE FROM ARTHRITIS.ORG

FIGURE 6. 1-CLIC PACKAGING
SYSTEM BY CENTOR
IMAGE FROM ARTHRITIS.ORG
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FIGURE 7. MEDICATION PACKAGING,
INDUSTRIAL, AND PRODUCT DESIGN
BY CHRISTINE CHAU
IMAGE FROM BEHANCE
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COGNITIVE IMPAIRMENT
The list of cognitive impairments is vast and
complicated, and that is why this thesis focuses on groups
of adults that are still able to perform activities of
daily life, or ADLs. The majority of targeted studies use
focus groups of adults 65 and older and use on average four
medications chronically. As we age, the possibility of a
memory or cognitive impairment increases. Types of
cognitive impairment most commonly include mild cognitive
impairments and types of dementia.
Dementia with Lewy bodies, or

DLB, accounts for 10 to

25% of dementia cases. Severity of confusion and alertness
vary from day to day and may include changes in thinking
and reasoning, visual hallucinations and delusions. Memory
loss may be significant but its less prominent than in
Alzheimers. Advanced DLB may cause memory problems in
addition to its more typical effects on judgment, planning
and visual perception.
Compared to Alzheimers, movement symptoms are more
likely to manifest early in DLB than in Alzheimer’s
progresses to moderate and severe stages later. Up to 5% of
the 5 million Americans with Alzheimers developed the the
early-onset cognitive impairment before the age of 65.
Early Alzheimers patients have trouble remembering recent
"22

conversations and names or events, which can cause a
serious mis-adherence in medication routines. Early on,
individuals can use pill organizers, calendars, and other
devices that can act as a reminder and prolong
independence. Later stages of Alzheimers include impaired
communication and difficulty speaking, which would make
communication with a pharmacist or caregiver difficult. At
that point in time, it is understood that variable required
assistance will be needed to monitor and administer
medication.
There are two different mild cognitive impairments, or
MCIs. Amnestic MCI patients forget information like
appointments, conversations, and recent events that would
otherwise be recalled easily. Non-amnestic MCIs have
difficulty in judging time, sequence of steps in a complex
task, making decisions, and visual perception. Non-amnestic
MCIs would be more common in adults that exhibit misadherence to medication routines. This can be supplemented
with pill organizers, calendars and reminders.
If multiple medications have been prescribed for other
serious health conditions, an organization system is
essential to avoid missed or incorrect dosage that could
lead to serious consequences (alz.org, 2017). A pill
organizer depends on the patient to understand their
medication direction from the pill bottle label and plan
accordingly for the week ahead. For my grandmother, this is
a problem as her mental health declines. My grandmother,
"23

for example, may use a pill organizer but often forgets
what day of the week it is. She believes she correctly took
her Thursday medicine, but it is a Friday. This can
seriously hurt her medication routine given that she may
only take one medication every other day, but she
accidentally ingests it two days in a row. For this reason,
my mother is investing in a low grade multi-compartment
medication device (MMD). From there, we will see if my
grandmother is able to load her medication correctly
herself.
It is common that elderly patients may be taking more
than four medications, so the use of a MMD would come in
handy. MMDs have been evaluated in multiple studies from
usability to emotional experiences related to them. In a
study done in the UK on MMD ease of use, researchers found
that the most valuable criterion for a successful MMD would
exhibit readable text, easily opened compartments including
removal, and the ability to transport the device. In this
study, nearly all participants lived on their own at home
with five as the median number of medications prescribed.
Three major commercial MMDs were evaluated against each
other and summarized by a formulated score. The three MMDs
were the Venalink®, the Dossett®, and the Nomad Clear® and
they’re shown in a figure table from the published research
document.
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FIGURE 8. TABLE DATA AND IMAGES OF MMDS: THE
DOSSETT, THE NOMAD CLEAR, AND THE VENALINK.
FONT SIZES SUMMARIZED BELOW THEIR RESPECTIVE
IMAGE.
TABLE AND IMAGES FROM ADAMS, 2013
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The Venalink had reasonable text, but the reflective
surface it was printed on took away from the clarity.
Similarly, the Nomad and Venalink were agreed to have
better visibility if printed on a different colored
surface. Type size for the Nomad and Dossett were too
small. The visual problems create complications before
there is evidence of cognitive impairment.
Moreover, the most negatively reviewed MMD was the
Vanalink because of ease of opening and removal of
medication and was particularly worse with cognitively
impaired patients. This study summarizes the main problem
by claiming “healthcare professionals may need to be aware
of such sensitivities when involving a patient in decisionmaking” (Adams, 2013). User testing is paramount when
creating devices that patients use so often their lives may
depend on its success.
Successful features can be seen in recent automatic
dispensers. The MedReady by MedReady, Inc. incorporates a
function that uses both a loud alarm as a reminder for up
to four doses of medication per day. If the patient is hard
of hearing or deaf, a bright red flashing light is an
optional add on that will appear along with the alarm. The
MedReady also uses a rechargeable battery that can generate
power for 48 hours if unconnected from a power source in
the event of traveling or a power outage.
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FIGURE 9. MEDREADY MMD BY MEDREADY, INC.
TOP-DOWN VIEW SHOWS THE PATIENT PERSPECTIVE, AN
OPEN COMPARTMENT AND TIME DISPLAY ON LID.
IMAGE FROM MEDREADY, INC.
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If the patient is still unable to adhere to the regimen,
the MedReady sends a message to the MedReady, Inc. data
centers to notify the caregiver via text message, email, or
an automated phone call. Although this device is not a
beautiful design, it appears as a device that is not to be
tampered with. By hindering the patient from tampering,
this keeps them honest to the routine and safe from
overmedicating. The only way to open the compartment is to
have a key that unlocks the lid, which reveals the
compartments and the functional buttons that control the
time display and alarm systems. Problems with this design
is that each dose takes up would be a compartment for
another day. In other words, if a patient takes medication
at four different times in the day, then each day takes up
four compartments, not one. This creates a problem with the
frequency in which the MMD needs to be planned and
refilled. This would require the patient to accurately
refill themselves or call on a caregiver more often to
organize the MMD, thus minimizing the independence the MMD
is meant to provide the patient.
There are more studies that need to be done on how the
MMDs work for independent senior patients living at home.
Adherence is directly dependent on not only memory or
cognition of how, when, and where to take medication, but
also on how the MMD is perceived such as how the text is
read and how much the patient themselves can interact with
the medication loading and dispensing (McGraw, 2004)
"28

THE SOLUTION
Systemic change is possible, but can be expensive.
Preparation, marketing, and regulations will make any
solution involving the pharmaceutical industry and
government a difficult one.
Manufacturers need to be prepared years in advance of
release. Brand managers and product designers must
communicate the color of medication class ahead of time so
that they are prepared for what colors are used, the
sequence, and the frequency of changes that will need to
made during production. Multi-year stability experiments
will need to take place to ensure the longevity and
endurance of the solution. Stability testing is costly as
well as the steps that precede it including, but not
limited to, design, rapid prototyping, user testing,
marketing and proposals. As mentioned before, IDARI offers
ease of use testing, but a single design can cost upwards
of $6,000. This may seem like a drop in the bucket for
government spending, but there must be significant backing
for a concept that will be released on a national scale and
as eventual policy. After the product is released, there
will more than likely be changes proposed, and system-wide
modifications may be difficult to achieve. Safety and
quality considerations must be balanced with cost
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considerations, especially with concern to government if
this is a product that will suggest a national standard
with policy requirements.
DESIGN
Summarizing the perceived successes and failures of
the previously mentioned case studies, completion the ideal
design will be a long road to pave. There may not be an
answer for a singular design that is accessible and
feasible for all, but there are design choices that can be
addressed and implemented across the board.
The ideal visual solution would use a typeface similar
to Maxular Rx, perhaps a condensed version if possible. As
for now, Maxular Rx is considered inefficient in terms of
space and reading on a small surface. A condensed version
would allow maximum readability at small sizes, even for
those with signs of macular degeneration. Type size should
generally not be smaller than 8 pt on a paper sticker label
attached to a bottle, but should allow for efficient
readability without turning the bottle. Color should be
used in tandem with pattern, for quick identification and a
failsafe for patients with color-blindness. Patterns that
are able to be modeled into a 3D texture will further
benefit patients that develop severely blurry or dark
vision and are unable to read words or perceive shape and
color. Speculative design thinking will lend itself to
voice recordings that with the push of a button, voice what
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medication it is, who it is intended for, how to take it,
and if there are any messages such as if a refill is
needed.
The ideal physical solution would have a variety of
options seeing as how arthritis can effect specific parts
of the hands and wrist, each different. Combinations that
allow the user to push a small button for a flip cap would
be ideal, especially if the lid can close with a “click”,
informing the user that the cap is correctly secured for
storage. Upon opening the bottle or compartment holding the
prescription, the user is allowed enough room to reach into
and grab a single pill, no matter the size. Better yet, the
patient is able to dispense only a single pill that is
released directly into their palm.
The ideal cognitive solution is multifaceted for
reasons of convenience and severity of mental decline. Pill
boxes, calendars, and organizers are not enough. MMDs are
safe and efficient, but are unapproachable for the patient
and do not have a friendly interface for the caregiver. An
ideal MMD would have pill bottles dispense directly from
the bottle, revealing the correct medication at the
designated time and day. This would essentially eliminate
“the middle man” that is specific to pill compartments. At
the that the patient needs to take the prescription, the
pill(s) would drop from the container(s) into a singular
tray that is secured by the seniors biometric data (a
fingerprint). The senior would hear a loud chiming sound,
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notifying them that their prescription is ready. In
addition, there are remote LEDs that can be placed around
the living space that softly flash for a patient unable to
hear. The senior that has a smart phone or tablet would
also get a notification on their device notifying them of
any important information. This UI would be reflected on
the physical interface of the device, where they can see
the name of the patient, the medication name, and any other
notifications like if they need to re-fill their
prescription. This option would allow the patient to
automatically refill their prescription with the option of
delivery to their home, and further assistance installing
with the help of a pharmacy technician assistant. If an
auto-refill is not approved, they have the option to video
call their pharmacist, and leave a video message if there
pharmacist is unable to answer.
The patient could come back to their device at another
time, and see if there is a notification from their
pharmacist saying the auto-refill is approved or not. The
dashboard where the patient receives these notifications
would also provide general information, instructions, and
warnings that are also available on the patient pamphlet
normally attached to the prescription packaging the bottle
comes in.
PRODUCTION
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Types of molds affect how cheap production would be
for a systematic change for prescription bottle packaging
design. This is a factor that could make or break the
production of a solution, thus the knowledge of current
manufacturing technology is helpful in pitching the
concept.
Different manufacturing techniques include
thermoforming, vacuum molds, extruded blow molding, and
injection molds. Thermoforming is a manufacturing method
that uses heat and pressure but can only be used to create
solid or flat items. A functional derivative of this
technique is vacuum molding. Vacuum molds work by heating a
sheet of plastic to a forming temperature then stretching
and forcing the material against the mold by a vacuum.
These are usually used for protective coverings, but it is
possible to create hollow shapes. An advantage of this
method is that color changes are easy, but the simplicity
of the shape made from this production technique is not
right for prescription bottle or cap design at this time.
Another form of production is extruded blow molding.
Fast production time makes for lower unit prices and
tooling costs less than injection molding, but is still
expensive. With extrusion blow molding, hollow parts are
possible and there are a broad range of materials with the
availability of different physical properties. This means
that bottles are a possibility for both plastic and glass.
The disadvantages are that both the tooling and machinery
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are expensive, so there are large minimum orders. Long
machine setups and production runs make color changes time
consuming and expensive, thus extruded blow molding would
not be the best route for a solution that relies on
implementing bottle or cap color. In addition, the design
is not as precise as injection molding, which would prevent
the use of textural patterns for those with visual
impairment.
Injection molding is the best solution for production.
Injection molds work by using high pressure conditions and
using heat softened materials (Zema, 2012). The material is
shaped in a mold cavity that provides the most intricacy of
any of the previously listed production methods. There is
no need for water or solvents, making production cheaper.
Continuous manufacturing makes production faster and more
efficient, adding to the products scalability. The
precision of the mold allows for versatility in design,
making the use of pattern and texture feasible in the
design. In regards to 3D printing, where rapid prototyping
and intricate forms can be tested, the two complement each
other in production. In this case, a cap or bottle can be
used in user testing before ever hitting the market and if
testing is successful, mass production can roll forward
with injection molding. In mass quantity, a new design can
be presented as low cost for the manufacturer and high
quality for the patient.
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A user interface that is constructed with an MMD would
take years to execute in both terms of design, research,
physical manufacturing, and software engineering. Existing
technology may be obsolete by the time this is released,
but transitional technology available now such as RFID
tags, NFC chips, and biometric scanners are small enough to
implement in so many different iterations. It is difficult
to speculate what this product would look like, but further
exploration would be beneficial in partnership with
industrial designers, user experience designers, user
interface designers, and service designers.
CONCLUSION
This thesis was meant to bring to attention the
current stage of prescription design for the impaired and
offer speculative design suggestions that may benefit both
the patient and the healthcare industry as a whole. Medical
mis-adherence is a serious problem that can be solved with
the use of empathetic human-centered design, careful
planning, and acceptance from the parties that control what
is standard. With the possibilities that technology offers
today, there are endless solutions waiting to be explored.
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